Sales grew 1% with stable margins and improved cash flow, driven by Medtech margin gains and cost reductions. Acquisition of BonsaiLab and Camanio closure support long-term strategy and profitability.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.